These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 31895772)
21. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay. Zhang L; Sun L; Zhang B; Chen L Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312 [TBL] [Abstract][Full Text] [Related]
22. Screening of potential hub genes and key pathways associated with breast cancer by bioinformatics tools. Oumeddour A Medicine (Baltimore); 2023 Mar; 102(11):e33291. PubMed ID: 36930083 [TBL] [Abstract][Full Text] [Related]
23. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer. Qiu P; Guo Q; Yao Q; Chen J; Lin J PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837 [TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis. Wu JR; Zhao Y; Zhou XP; Qin X Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575 [TBL] [Abstract][Full Text] [Related]
25. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis. Li T; Gao X; Han L; Yu J; Li H World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304 [TBL] [Abstract][Full Text] [Related]
26. Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics. Cai K; Xie Z; Liu Y; Wu J; Song H; Liu W; Wang X; Xiong Y; Gan S; Sun Y Biomed Res Int; 2023; 2023():2152432. PubMed ID: 36714024 [TBL] [Abstract][Full Text] [Related]
27. High Expression of Deng H; Huang Y; Wang L; Chen M Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373 [TBL] [Abstract][Full Text] [Related]
28. Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation. Wang N; Zhang H; Li D; Jiang C; Zhao H; Teng Y Bioengineered; 2021 Dec; 12(2):12431-12446. PubMed ID: 34895070 [TBL] [Abstract][Full Text] [Related]
29. Common gene signatures and key pathways in hypopharyngeal and esophageal squamous cell carcinoma: Evidence from bioinformatic analysis. Zhou R; Liu D; Zhu J; Zhang T Medicine (Baltimore); 2020 Oct; 99(42):e22434. PubMed ID: 33080677 [TBL] [Abstract][Full Text] [Related]
30. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics. Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725 [TBL] [Abstract][Full Text] [Related]
31. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis. Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846 [No Abstract] [Full Text] [Related]
32. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer. Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032 [TBL] [Abstract][Full Text] [Related]
33. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis. Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311 [TBL] [Abstract][Full Text] [Related]
34. Identification of Biomarkers for Ovarian Cancer Diagnosis and Prognosis by Bioinformatics Analysis and q-PCR Validation. Zheng Q; Ye H; Zhong H; Wang M Ann Clin Lab Sci; 2022 Nov; 52(6):967-975. PubMed ID: 36564071 [TBL] [Abstract][Full Text] [Related]
35. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments. Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343 [TBL] [Abstract][Full Text] [Related]
36. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis. Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978 [TBL] [Abstract][Full Text] [Related]
37. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer. Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591 [No Abstract] [Full Text] [Related]
38. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
39. Identification of crucial genes associated with lung adenocarcinoma by bioinformatic analysis. Dai JJ; Zhou WB; Wang B Medicine (Baltimore); 2020 Oct; 99(44):e23052. PubMed ID: 33126397 [TBL] [Abstract][Full Text] [Related]
40. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis. Sun Q; Liu P; Long B; Zhu Y; Liu T Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]